• Exchange: Copenhagen
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

ALK-Abello A/S

+ Add to Watchlist

ALKB:DC

716.000 DKK 17.000 2.32%

As of 11:03:47 ET on 09/19/2014.

Snapshot for ALK-Abello A/S (ALKB)

Open: 737.000 Day's Range: 690.000 - 738.000 Volume: 11,727
Previous Close: 733.000 52wk Range: 470.000 - 870.000 1-Yr Rtn: +49.83%

Stock Chart for ALKB

No chart data available.
  • ALKB:DC 716.000
  • 1D
  • 1M
  • 1Y
733.000
Interactive ALKB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ALKB

Current P/E Ratio (ttm) 36.7934
Estimated P/E(12/2014) 35.9005
Relative P/E vs. KFX 1.5871
Earnings Per Share (DKK) (ttm) 19.4600
Est. EPS (DKK) (12/2014) 19.9440
Est. PEG Ratio -
Market Cap (M DKK) 7,251.91
Shares Outstanding (M) 9.21
30 Day Average Volume 9,987
Price/Book (mrq) 3.0097
Price/Sale (ttm) 2.8810
Dividend Indicated Gross Yield 0.70%
Cash Dividend (DKK) 5.0000
Dividend Ex-Date 03/13/2014
5 Year Dividend Growth 0.00%
Next Earnings Announcement 11/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ALKB

  • Revenue
  • Net Income (M/DKK)
  • Profit Margin (%)

Company Profile & Key Executives for ALKB

Alk-Abello A/S produces pharmaceuticals for allergy vaccination. The Company is an international group with subsidiaries and associated companies worldwide.

Jens BagerPresident/CEOSoren NiegelExec VP:Commercial Operations
Flemming PedersenExec VP:Finance & IT/CFOHenrik JacobiExec VP:Research & Dev
More Company Profile & Key Executives for ALKB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil